A Cost- and Environmentally Effective Approach to Supplying Nitrogen Gas to Pharmaceutical Manufacturing Industrial Facilities
The authors argue that the cost of generating nitrogen via an in-house gas generator is considerably lower than the cost of using fractional distillation to generate liquid nitrogen.
A Glass Act
Duke University researchers have found a possible alternative to lyophilization.
Exploring the Tools in Nanoparticle Analysis
Nanotechnology is an important area of drug and biomedical research, and advancing nano-analysis is crucial for its further development.
Statistical Solutions: On the Verge of Significance: Why 5%
A history of the selection of the widely used significance level leaves much to be desired.
Top-to-Bottom Collaboration
To continue innovating, the biopharmaceutical sector needs support from all levels.
Q&A with Metrics' David Varley
Varley, director of commercial operations, discusses one-stop shops and timelines.
Report from India
As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.
Statistical Considerations in Design Space Development (Part I of III)
The authors discuss the statistical tools used in experimental planning and strategy and how to evaluate the resulting design space and its graphical representation.
Comparison of Superdisintegrants in Orally Disintegrating Tablets
The functionality and performance of three types of commercial superdisintegrants were evaluated in the application of orally disintegrating tablets.
In the Spotlight July 2010
Editors' picks of pharmaceutical science and technology innovations.
Be Careful for What You Wish
Rising labor costs in China may result in increased competition for higher value services.
The Hour of the Particle
Is now the time for multiparticulates to shine as a controlled-release solution?
Novel Suppository Design for HIV Chemoprophylaxis
Technical Note: The authors investigated the variables important for calcium-alginate formation as well as dissolution.
Augmenting Excipient Functionality
Excipient manufacturers expand their products, services, manufacturing capacity, and technology positions.
The Cold Shoulder
Reports of overlooked controls, dropped pallets, and misplaced documents leave a chill in the air.
A Word to the Unwise
After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.
Transparency to Alter FDA and Industry Practices
More information may be released to improve public understanding of regulatory policies.
Pharmaceutical Technology, July 2010 Issue (PDF)
Multiparticulates in Controlled Release: Has Their Time Come?